Cargando…

Virtual and In Vitro Screening of Natural Products Identifies Indole and Benzene Derivatives as Inhibitors of SARS-CoV-2 Main Protease (M(pro))

SIMPLE SUMMARY: The coronavirus disease 2019 (COVID-19) pandemic caused more than 6.7 million deaths worldwide. Certain groups of individuals are still at a high risk of severe illness. The availability of drugs to treat COVID-19 symptoms will save many lives. The main protease (M(pro)) of SARS-CoV2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ang, Dony, Kendall, Riley, Atamian, Hagop S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135783/ https://www.ncbi.nlm.nih.gov/pubmed/37106720 http://dx.doi.org/10.3390/biology12040519

Ejemplares similares

Discovery of novel SARS-CoV-2 inhibitors targeting the main protease M(pro) by virtual screenings and hit optimization
por: Mercorelli, Beatrice, et al.
Publicado: (2022)

Pharmacophore based virtual screening for natural product database revealed possible inhibitors for SARS-COV-2 main protease
por: El-Ashrey, Mohamed K., et al.
Publicado: (2022)

Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease
por: Marinho, Emanuelle Machado, et al.
Publicado: (2020)

Computer-aided drug design for virtual-screening and active-predicting of main protease (M(pro)) inhibitors against SARS-CoV-2
por: Dai, Renhui, et al.
Publicado: (2023)

Discovery of Diverse Natural Products as Inhibitors of SARS-CoV-2 M(pro) Protease through Virtual Screening
por: Rubio-Martínez, Jaime, et al.
Publicado: (2021)

Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
por: Luttens, Andreas, et al.
Publicado: (2022)

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
por: Jiménez-Alberto, Alicia, et al.
Publicado: (2020)

Screening, molecular simulation & in silico kinetics of virtually designed covid-19 main protease inhibitors
por: Aleissa, Mohammed S., et al.
Publicado: (2022)

Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (M(pro))
por: Sayed, Ahmed M., et al.
Publicado: (2020)

In silico approach for identification of natural compounds as potential COVID 19 main protease (M(pro)) inhibitors
por: Chaturvedi, Monika, et al.
Publicado: (2021)

Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
por: Kandeel, Mahmoud, et al.
Publicado: (2020)

Virtual screening of peptides with high affinity for SARS-CoV-2 main protease
por: Porto, William Farias
Publicado: (2021)

Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study
por: Bolelli, Kayhan, et al.
Publicado: (2021)

High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2
por: Olubiyi, Olujide O., et al.
Publicado: (2020)

Selection of SARS-CoV-2 main protease inhibitor using structure-based virtual screening
por: Hakami, Abdulrahim R, et al.
Publicado: (2021)

Identification of promising high-affinity inhibitors of SARS-CoV-2 main protease from African Natural Products Databases by Virtual Screening
por: DIABATE, Oudou, et al.
Publicado: (2023)

Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M(pro) Main Protease Inhibitors
por: Peralta-Moreno, Maria Nuria, et al.
Publicado: (2023)

Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL(PRO) and 3CL(PRO) proteases
por: Jade, Dhananjay, et al.
Publicado: (2021)

Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
por: Sanachai, Kamonpan, et al.
Publicado: (2022)

Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae
por: Rauf, Abdur, et al.
Publicado: (2021)

Virtual Screening of Artemisia annua Phytochemicals as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme
por: Miandad, Khalid, et al.
Publicado: (2022)

The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (M(pro))
por: Ebrahim, Ali, et al.
Publicado: (2021)

Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs
por: Li, Zhe, et al.
Publicado: (2020)

Computational investigation of natural compounds as potential main protease (M(pro)) inhibitors for SARS-CoV-2 virus
por: Patel, Chirag N., et al.
Publicado: (2022)

Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds
por: Fischer, André, et al.
Publicado: (2020)

ADMET profile and virtual screening of plant and microbial natural metabolites as SARS-CoV-2 S1 glycoprotein receptor binding domain and main protease inhibitors
por: Padhi, Srichandan, et al.
Publicado: (2021)

Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
por: Gentile, Davide, et al.
Publicado: (2020)

Virtual screening for small molecular non-covalent binders of the SARS-CoV-2 main protease
por: Lipiński, Piotr F.J., et al.
Publicado: (2021)

De novo Sequencing and Analysis of Salvia hispanica Tissue-Specific Transcriptome and Identification of Genes Involved in Terpenoid Biosynthesis
por: Wimberley, James, et al.
Publicado: (2020)

In-silico screening of naturally derived phytochemicals against SARS-CoV Main protease
por: Mostafa, Islam, et al.
Publicado: (2021)

Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease
por: Selvaraj, Chandrabose, et al.
Publicado: (2021)

In Silico Identification of New Anti-SARS-CoV-2 Main Protease (M(pro)) Molecules with Pharmacokinetic Properties from Natural Sources Using Molecular Dynamics (MD) Simulations and Hierarchical Virtual Screening
por: Onyango, Harrison, et al.
Publicado: (2022)

Haste makes waste: A critical review of docking‐based virtual screening in drug repurposing for SARS‐CoV‐2 main protease (M‐pro) inhibition
por: Macip, Guillem, et al.
Publicado: (2021)

Screening of natural compounds from Cyperus rotundus Linn against SARS-CoV-2 main protease (M(pro)): An integrated computational approach
por: Kumar, S. Birendra, et al.
Publicado: (2021)

Antiviral Activity of an Indole-Type Compound Derived from Natural Products, Identified by Virtual Screening by Interaction on Dengue Virus NS5 Protein
por: García-Ariza, Leidy Lorena, et al.
Publicado: (2023)

The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (M(pro))
por: Ebrahim, Ali, et al.
Publicado: (2022)

Discovery of novel inhibitors against main protease (Mpro) of SARS-CoV-2 via virtual screening and biochemical evaluation
por: Guo, Sheng, et al.
Publicado: (2021)

Structure-Based Virtual Screening and Biochemical Validation to Discover a Potential Inhibitor of the SARS-CoV-2 Main Protease
por: Gupta, Akshita, et al.
Publicado: (2020)

Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study
por: Wang, Hu, et al.
Publicado: (2022)

Finding potential inhibitors for Main protease (Mpro) of SARS-CoV-2 through virtual screening and MD simulation studies
por: Ahamed, N. Anis, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_krk24qpo3eara2p9t5aqd05198